{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:38:36Z","timestamp":1786995516779,"version":"build-2736575974"},"reference-count":95,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.path.2023.04.003","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T03:29:18Z","timestamp":1683084558000},"page":"473-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systemic Disease and the Liver-Part 1"],"prefix":"10.1016","volume":"16","author":[{"given":"Maria Isabel","family":"Fiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.path.2023.04.003_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.path.2023.04.003_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/0961203320923398","article-title":"Hepatic manifestations in systemic lupus erythematosus","volume":"29","author":"Gonz\u00e1lez-Regueiro","year":"2020","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.path.2023.04.003_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4254\/wjh.v6.i6.394","article-title":"Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis","volume":"6","author":"Bessone","year":"2014","journal-title":"World J Hepatol"},{"issue":"2","key":"10.1016\/j.path.2023.04.003_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9343(80)90378-2","article-title":"The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature","volume":"69","author":"Runyon","year":"1980","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.path.2023.04.003_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.rdc.2017.09.011","article-title":"Gastrointestinal and Hepatic Disease in Systemic Lupus Erythematosus","volume":"44","author":"Brewer","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.path.2023.04.003_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/03009742.2020.1744712","article-title":"Lupus hepatitis, more than just elevated liver enzymes","volume":"49","author":"Afzal","year":"2020","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.path.2023.04.003_bib7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MCG.0b013e31820f81b8","article-title":"Gastrointestinal and hepatic manifestations of systemic lupus erythematosus","volume":"45","author":"Ebert","year":"2011","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.path.2023.04.003_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00296-020-04717-y","article-title":"Acute liver failure as the first feature of systemic lupus erythematosus","volume":"41","author":"Mustafa","year":"2021","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bpg.2013.06.016","article-title":"Liver abnormalities in connective tissue diseases","volume":"27","author":"De Santis","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.path.2023.04.003_bib10","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3899\/jrheum.080336","article-title":"Liver involvement in systemic lupus erythematosus: case review of 40 patients","volume":"35","author":"Chowdhary","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.path.2023.04.003_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/0961203317707825","article-title":"Gastrointestinal system involvement in systemic lupus erythematosus","volume":"26","author":"Li","year":"2017","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.path.2023.04.003_bib12","first-page":"471","article-title":"Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus","volume":"39","author":"Lu","year":"2006","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"5","key":"10.1016\/j.path.2023.04.003_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1034\/j.1600-0676.2000.020005366.x","article-title":"The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver","volume":"20","author":"Matsumoto","year":"2000","journal-title":"Liver"},{"issue":"8","key":"10.1016\/j.path.2023.04.003_bib14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/00365521.2017.1311936","article-title":"Clinical and histologic features of Azathioprine-induced hepatotoxicity","volume":"52","author":"Siramolpiwat","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"13","key":"10.1016\/j.path.2023.04.003_bib15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2169\/internalmedicine.52.9458","article-title":"Liver dysfunction in patients with systemic lupus erythematosus","volume":"52","author":"Takahashi","year":"2013","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.amjms.2016.10.014","article-title":"Lupus Hepatitis and Autoimmune Hepatitis (Lupoid Hepatitis)","volume":"353","author":"Adiga","year":"2017","journal-title":"Am J Med Sci"},{"issue":"211","key":"10.1016\/j.path.2023.04.003_bib17","first-page":"401","article-title":"The liver in systemic lupus erythematosus","volume":"53","author":"Miller","year":"1984","journal-title":"Q\u00a0J Med"},{"issue":"23","key":"10.1016\/j.path.2023.04.003_bib18","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3748\/wjg.v28.i23.2527","article-title":"Autoimmune liver diseases in systemic rheumatic diseases","volume":"28","author":"Wang","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.path.2023.04.003_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/1872213X07666131229110501","article-title":"Hepatic manifestations in juvenile systemic lupus erythematosus","volume":"8","author":"El-Shabrawi","year":"2014","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib20","first-page":"504","article-title":"Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis","volume":"28","author":"Piga","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.path.2023.04.003_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3760\/cma.j.issn.0366-6999.20121153","article-title":"Clinical and immunopathological features of patients with lupus hepatitis","volume":"126","author":"Zheng","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.path.2023.04.003_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.immunol.22.012703.104549","article-title":"The role of complement in the development of systemic lupus erythematosus","volume":"22","author":"Manderson","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"10.1016\/j.path.2023.04.003_bib23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3109\/00365521.2011.558114","article-title":"Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases","volume":"46","author":"Efe","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.path.2023.04.003_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.humpath.2018.07.014","article-title":"Histologic features of autoimmune hepatitis: a critical appraisal","volume":"82","author":"Gurung","year":"2018","journal-title":"Hum Pathol"},{"issue":"Suppl 2","key":"10.1016\/j.path.2023.04.003_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000440747","article-title":"Role of Histopathology in Autoimmune Hepatitis","volume":"33","author":"Tiniakos","year":"2015","journal-title":"Dig Dis"},{"issue":"20","key":"10.1016\/j.path.2023.04.003_bib26","doi-asserted-by":"crossref","first-page":"e20192","DOI":"10.1097\/MD.0000000000020192","article-title":"Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib27","first-page":"410","article-title":"Nodular transformation of the liver in a patient with systemic lupus erythematosus","volume":"16","author":"Hubscher","year":"1989","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.path.2023.04.003_bib28","first-page":"428269","article-title":"Thrombosis in systemic lupus erythematosus: a review article","volume":"2012","author":"Al-Homood","year":"2012","journal-title":"ISRN Rheumatol"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/03009749709065684","article-title":"Nodular regenerative hyperplasia of the liver in systemic lupus erythematosus. The relationship with anticardiolipin antibody and lupus anticoagulant","volume":"26","author":"Sekiya","year":"1997","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/09612033707076513","article-title":"Unique hepatic imaging features in a patient with nodular regenerative hyperplasia of the liver associating with systemic lupus erythematosus","volume":"16","author":"Leung","year":"2007","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2214\/ajr.148.4.717","article-title":"Nodular regenerative hyperplasia of the liver: clinical and radiologic observations","volume":"148","author":"Dachman","year":"1987","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.path.2023.04.003_bib32","doi-asserted-by":"crossref","first-page":"e0120299","DOI":"10.1371\/journal.pone.0120299","article-title":"Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement","volume":"10","author":"Jharap","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.path.2023.04.003_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cld.2018.12.001","article-title":"The Liver and Celiac Disease","volume":"23","author":"Rubio-Tapia","year":"2019","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.path.2023.04.003_bib34","first-page":"116","article-title":"Celiac Disease and Elevated Liver Enzymes: A Review","volume":"9","author":"Villavicencio Kim","year":"2021","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"11","key":"10.1016\/j.path.2023.04.003_bib35","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1111\/liv.15000","article-title":"High prevalence of celiac disease in autoimmune hepatitis: Systematic review and meta-analysis","volume":"41","author":"Hagg\u00e5rd","year":"2021","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.path.2023.04.003_bib36","first-page":"44","article-title":"Prevalence of Celiac Disease in Patients with Primary Biliary Cholangitis","volume":"4","author":"Callichurn","year":"2021","journal-title":"J\u00a0Can Assoc Gastroenterol"},{"issue":"1","key":"10.1016\/j.path.2023.04.003_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1309\/AJCPDOMY5RI5TPMN","article-title":"The liver in celiac disease: clinical manifestations, histologic features, and response to gluten-free diet in 30 patients","volume":"136","author":"Mounajjed","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.gtc.2012.06.004","article-title":"Celiac disease","volume":"41","author":"Evans","year":"2012","journal-title":"Gastroenterol Clin North Am"},{"issue":"2","key":"10.1016\/j.path.2023.04.003_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamaoncol.2021.5680","article-title":"Immune-Mediated Diseases Associated With Cancer Risks","volume":"8","author":"He","year":"2022","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.path.2023.04.003_bib40","doi-asserted-by":"crossref","first-page":"820","DOI":"10.14309\/ajg.0000000000002123","article-title":"Prevalence of celiac disease in patients with liver diseases: a systematic review and meta-analyses","volume":"118","author":"Yoosuf","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00042737-199903000-00012","article-title":"Prevalence and clinical importance of hypertransaminasaemia in coeliac disease","volume":"11","author":"Novacek","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.path.2023.04.003_bib42","first-page":"595","article-title":"Liver involvement in celiac disease","volume":"99","author":"Rubio-Tapia","year":"2008","journal-title":"Minerva Med"},{"issue":"5","key":"10.1016\/j.path.2023.04.003_bib43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jclinpath-2017-204647","article-title":"Coeliac disease and the liver: spectrum of liver histology, serology and treatment response at a tertiary referral centre","volume":"71","author":"Majumdar","year":"2018","journal-title":"J\u00a0Clin Pathol"},{"issue":"12","key":"10.1016\/j.path.2023.04.003_bib44","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/MEG.0000000000002455","article-title":"Long-term follow-up and prognosis of celiac hepatitis","volume":"34","author":"Garrido","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MEG.0000000000002234","article-title":"Nonalcoholic fatty liver disease is associated with a higher incidence of coeliac disease","volume":"34","author":"Roderburg","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.path.2023.04.003_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4065\/81.1.94","article-title":"Genetics of rheumatoid arthritis","volume":"81","author":"Turesson","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.path.2023.04.003_bib47","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00296-021-04804-8","article-title":"Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study)","volume":"41","author":"Feuchtenberger","year":"2021","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.path.2023.04.003_bib48","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jaad.2021.02.019","article-title":"Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study","volume":"84","author":"Gelfand","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrrheum.2010.214","article-title":"Hepatotoxicity related to antirheumatic drugs","volume":"7","author":"Aithal","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib50","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/imj.15125","article-title":"Assessment of liver fibrosis markers in people with rheumatoid arthritis on methotrexate","volume":"52","author":"Olsson-White","year":"2022","journal-title":"Intern Med J"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/1573397116666200319155247","article-title":"Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate","volume":"16","author":"Hilal","year":"2020","journal-title":"Curr Rheumatol Rev"},{"issue":"1","key":"10.1016\/j.path.2023.04.003_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.rdc.2017.09.005","article-title":"Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis","volume":"44","author":"Craig","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"issue":"Suppl 2","key":"10.1016\/j.path.2023.04.003_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000440707","article-title":"Association of Extrahepatic Manifestations with Autoimmune Hepatitis","volume":"33","author":"Wong","year":"2015","journal-title":"Dig Dis"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2169\/internalmedicine.44.335","article-title":"Felty's syndrome with chronic hepatitis and compatible autoimmune hepatitis: a case presentation","volume":"44","author":"Sema","year":"2005","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.path.2023.04.003_bib55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/rheumatology\/36.2.210","article-title":"Histologic liver abnormalities in an autopsy series of patients with rheumatoid arthritis","volume":"36","author":"Ruderman","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"7","key":"10.1016\/j.path.2023.04.003_bib56","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/ard.50.7.477","article-title":"Hepatic methotrexate content and progression of hepatic fibrosis: preliminary findings","volume":"50","author":"Ahern","year":"1991","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib57","first-page":"197","article-title":"Hepatotoxicity of methotrexate in rheumatic diseases","volume":"3","author":"Kevat","year":"1988","journal-title":"Med Toxicol Adverse Drug Exp"},{"issue":"12","key":"10.1016\/j.path.2023.04.003_bib58","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1440-1746.2001.02644.x","article-title":"Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury","volume":"16","author":"Langman","year":"2001","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.path.2023.04.003_bib59","doi-asserted-by":"crossref","first-page":"e0203084","DOI":"10.1371\/journal.pone.0203084","article-title":"Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment","volume":"13","author":"Mori","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.path.2023.04.003_bib60","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00004836-200210000-00020","article-title":"Nodular regenerative hyperplasia in a rheumatoid arthritis patient without felty's syndrome","volume":"35","author":"Goritsas","year":"2002","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.path.2023.04.003_bib62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00004836-198902000-00024","article-title":"Sinusoidal lymphocytosis of the liver in Felty's syndrome with a review of the liver involvement in Felty's syndrome","volume":"11","author":"Cohen","year":"1989","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.path.2023.04.003_bib63","first-page":"1961","article-title":"Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis","volume":"8","author":"Osuga","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"10.1016\/j.path.2023.04.003_bib64","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib65","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.path.2023.04.003_bib66","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10735-020-09915-3","article-title":"COVID-19 and multiorgan failure: A narrative review on potential mechanisms","volume":"51","author":"Mokhtari","year":"2020","journal-title":"J\u00a0Mol Histol"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib67","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jcmgh.2020.09.015","article-title":"Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection","volume":"11","author":"Fiel","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib68","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s12072-022-10364-1","article-title":"SARS-CoV-2 infection and liver involvement","volume":"16","author":"Luo","year":"2022","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib69","first-page":"e72","article-title":"Hepatic manifestations and complications of COVID-19: A systematic review and meta-analysis","volume":"81","author":"Kunutsor","year":"2020","journal-title":"J\u00a0Infect"},{"issue":"8","key":"10.1016\/j.path.2023.04.003_bib70","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41379-021-00793-y","article-title":"Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience","volume":"34","author":"Bryce","year":"2021","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib71","doi-asserted-by":"crossref","first-page":"e0250708","DOI":"10.1371\/journal.pone.0250708","article-title":"Pathological findings in organs and tissues of patients with COVID-19: A systematic review","volume":"16","author":"Peiris","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib72","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","article-title":"SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19","volume":"73","author":"Wang","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.path.2023.04.003_bib73","first-page":"e25","article-title":"Acute hepatitis caused by asymptomatic COVID-19 infection","volume":"82","author":"Bongiovanni","year":"2021","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.path.2023.04.003_bib74","doi-asserted-by":"crossref","first-page":"749318","DOI":"10.3389\/fmed.2021.749318","article-title":"Liver Histopathological Analysis of 24 Postmortem Findings of Patients With COVID-19 in China","volume":"8","author":"Chu","year":"2021","journal-title":"Front Med"},{"issue":"8","key":"10.1016\/j.path.2023.04.003_bib75","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.arcped.2020.09.009","article-title":"Fulminant hepatic failure: A rare and devastating manifestation of Coronavirus disease 2019 in an 11-year-old boy","volume":"27","author":"Haji Esmaeil Memar","year":"2020","journal-title":"Arch Pediatr"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib76","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jhep.2021.04.050","article-title":"Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy","volume":"75","author":"McConnell","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.path.2023.04.003_bib77","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12072-020-10072-8","article-title":"Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)","volume":"14","author":"Sarin","year":"2020","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.path.2023.04.003_bib78","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2020.06.001","article-title":"High\u00a0rates of 30-day mortality in patients with cirrhosis and COVID-19","volume":"73","author":"Iavarone","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.path.2023.04.003_bib79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MOG.0000000000000808","article-title":"Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies","volume":"38","author":"Bartoli","year":"2022","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"10.1016\/j.path.2023.04.003_bib80","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.14309\/ajg.0000000000001154","article-title":"Post-COVID-19 Cholangiopathy: A Novel Entity","volume":"116","author":"Roth","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.path.2023.04.003_bib81","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.14309\/ajg.0000000000001264","article-title":"Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications","volume":"116","author":"Faruqui","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.path.2023.04.003_bib82","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.5858\/arpa.2021-0605-SA","article-title":"Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients","volume":"146","author":"Shih","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.path.2023.04.003_bib83","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.32582","article-title":"Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease","volume":"76","author":"Hartl","year":"2022","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.path.2023.04.003_bib84","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.32668","article-title":"COVID-19-associated cholangiopathy: What is left after the virus has gone?","volume":"76","author":"Heucke","year":"2022","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.path.2023.04.003_bib85","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.transproceed.2021.03.007","article-title":"Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report","volume":"53","author":"Durazo","year":"2021","journal-title":"Transplant Proc"},{"issue":"10","key":"10.1016\/j.path.2023.04.003_bib86","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/liv.14971","article-title":"Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19","volume":"41","author":"B\u00fctikofer","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.path.2023.04.003_bib87","doi-asserted-by":"crossref","first-page":"102741","DOI":"10.1016\/j.jaut.2021.102741","article-title":"Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence","volume":"125","author":"Garrido","year":"2021","journal-title":"J\u00a0Autoimmun"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib88","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study","volume":"74","author":"Marjot","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.path.2023.04.003_bib89","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/MEG.0000000000001902","article-title":"Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study","volume":"33","author":"Mahamid","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.path.2023.04.003_bib90","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2020.09.006","article-title":"NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues","volume":"74","author":"Mushtaq","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.path.2023.04.003_bib91","article-title":"Drug-Induced Liver Injury in Hospitalized Patients during SARS-CoV-2 Infection","volume":"58","author":"Karlafti","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.path.2023.04.003_bib92","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2022.02.014","article-title":"Unexplained liver test elevations after SARS-CoV-2 vaccination","volume":"77","author":"Guardiola","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.path.2023.04.003_bib93","doi-asserted-by":"crossref","first-page":"100605","DOI":"10.1016\/j.jhepr.2022.100605","article-title":"Histological and serological features of acute liver injury after SARS-CoV-2 vaccination","volume":"5","author":"Codoni","year":"2023","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.path.2023.04.003_bib94","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jhep.2022.03.040","article-title":"SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis","volume":"77","author":"Boettler","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.path.2023.04.003_bib95","doi-asserted-by":"crossref","first-page":"102710","DOI":"10.1016\/j.jaut.2021.102710","article-title":"Autoimmune hepatitis triggered by SARS-CoV-2 vaccination","volume":"123","author":"Vuille-Lessard \u00c9","year":"2021","journal-title":"J\u00a0Autoimmun"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:43:54Z","timestamp":1761749034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918123000296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1875918123000296"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2023.04.003","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Disease and the Liver-Part 1","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2023.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}